Coronavirus

Need COVID treatment? New monoclonal antibody centers now open in South Florida

Aerial view of a monoclonal antibody treatment site for COVID-19 at Markham Park in Sunrise, Florida on Wednesday, January 19, 2022.
Aerial view of a monoclonal antibody treatment site for COVID-19 at Markham Park in Sunrise, Florida on Wednesday, January 19, 2022. mocner@miamiherald.com

Three new monoclonal antibody sites have opened in South Florida to meet demand for the scarce treatment, which can help keep high-risk people ill with COVID-19 out of the hospital.

The sites

In Miami-Dade, the new site is at Miami Dade College North Campus, 11380 NW 27th Ave. near Opa-locka, which already serves as a testing and vaccine site.

In Broward, the site is at Markham Park, 16001 W. State Rd 94 in Sunrise, which is also a testing site.

In Palm Beach County, the therapy is available at West Boynton Recreation Center, 6000 Northtree Blvd.

Workers can be seen outside of a monoclonal antibody treatment site for COVID-19 at Markham Park in Sunrise, Florida on Wednesday, January 19, 2022.
Workers can be seen outside of a monoclonal antibody treatment site for COVID-19 at Markham Park in Sunrise, Florida on Wednesday, January 19, 2022. MATIAS J. OCNER mocner@miamiherald.com

Hours and appointments

All three sites opened Tuesday morning. Hours are 9 a.m. to 5 p.m. seven days. The sites offer the treatment for free. New sites also opened Tuesday in Duval and Seminole counties. Appointments can be made at patientportalfl.com.

The new sites come after Florida saw a surge of cases during the holidays, with hospitalizations approaching records set during delta’s wave last year. Just like the demand for tests, people crowded treatment centers, with the sites at Tropical Park in Westchester and C.B. Smith Park in Pembroke Pines temporarily closing last month after running out of supplies.

The treatment

A woman can be seen leaving a monoclonal antibody treatment site for COVID-19 at Miami Dade College North Campus in Miami, Florida on Wednesday, January 19, 2022.
A woman can be seen leaving a monoclonal antibody treatment site for COVID-19 at Miami Dade College North Campus in Miami, Florida on Wednesday, January 19, 2022. MATIAS J. OCNER mocner@miamiherald.com

Florida Gov. Ron DeSantis has been calling on the federal government, which controls the supply of the monoclonal antibodies, to send more shipments to the state. On Jan. 7, he announced that 15,000 doses of Regeneron’s therapy, known as REGEN-COV, would become available to open new sites.

Read Next

The treatment is for people 12 and older who have tested positive or were exposed to COVID-19 and are considered to be “high risk” for severe COVID illness, including hospitalization and death. Monoclonal antibody treatments are designed to give the immune system an extra boost to help combat the disease, enough to hopefully keep them out of the hospital.

REGEN-COV is effective against the delta variant but may be less effective against the highly contagious omicron variant, which is now the dominant strain in Miami-Dade and the U.S., as the Miami Herald has reported. The monoclonal antibody treatment that appears to be the most effective against omicron is a drug called sotrovimab.

Aerial view of a monoclonal antibody treatment site for COVID-19 at Markham Park in Sunrise, Florida on Wednesday, January 19, 2022.
Aerial view of a monoclonal antibody treatment site for COVID-19 at Markham Park in Sunrise, Florida on Wednesday, January 19, 2022. MATIAS J. OCNER mocner@miamiherald.com

To learn more

To learn more about eligibility requirements or find other treatment sites in Florida, visit floridahealthcovid19.gov. You can also call the Florida Department of Health Monoclonal Antibody Treatment Support Line at 850-344-9637.

This story was originally published January 18, 2022 at 11:03 AM.

Michelle Marchante
Miami Herald
Michelle Marchante covers the pulse of healthcare in South Florida and also the City of Coral Gables. Before that, she covered the COVID-19 pandemic, hurricanes, crime, education, entertainment and other topics in South Florida for the Herald as a breaking news reporter. She recently won first place in the health reporting category in the 2025 Sunshine State Awards for her coverage of Steward Health’s bankruptcy. An investigative series about the abrupt closure of a Miami heart transplant program led Michelle and her colleagues to be recognized as finalists in two 2024 Florida Sunshine State Award categories. She also won second place in the 73rd annual Green Eyeshade Awards for her consumer-focused healthcare stories and was part of the team of reporters who won a 2022 Pulitzer Prize for the Miami Herald’s breaking news coverage of the Surfside building collapse. Michelle graduated with honors from Florida International University and was a 2025 National Press Foundation Covering Workplace Mental Health fellow and a 2020-2021 Poynter-Koch Media & Journalism fellow.  Support my work with a digital subscription
Get unlimited digital access
#ReadLocal

Try 1 month for $1

CLAIM OFFER